GLP-3 R Phase 2: −28.7%143 Compounds · 5 Layers>98% HPLC All VialsFree Shipping $200+Third-Party Test ReportsResearch Use OnlyCAS Numbers VerifiedGHK-Cu: 4,000+ GenesGLP-3 R Phase 2: −28.7%143 Compounds · 5 Layers>98% HPLC All VialsFree Shipping $200+Third-Party Test ReportsResearch Use OnlyCAS Numbers VerifiedGHK-Cu: 4,000+ Genes
Cagri-Reta 5mg
Stack

Cagri-Reta 5mg

Cagrilintide / Retatrutide

CAS: 2381089-29-0 / 2381089-83-2

$116.99$129.9910% OFFIn Stock

Cagri-Reta 5mg — entry vial for four-receptor metabolic research. Smaller format of the cagrilintide + retatrutide blend for dose-finding protocols. 98.5% HPLC purity.

Specifications

Vial Size5mg blend
FormLyophilized Powder
Purity98.5% HPLC
CAS2381089-29-0 / 2381089-83-2
Storage-20C long-term
Shop This Compound

For laboratory research use only. Not for human consumption.

Mechanism of Action

Same quad-receptor mechanism (AMY1/AMY3 + GLP-1R + GIPR + GcgR) as the 10mg blend at a lower total quantity for initial titration research.

Research FAQ

Is the 5mg blend in the same ratio as the 10mg?

Yes, same 1:1 cagrilintide:retatrutide blend ratio at half the total peptide quantity.

Related Compounds